ST3GAL2 Polyclonal antibody

ST3GAL2 Polyclonal Antibody for IHC, WB, ELISA

Host / Isotype

Rabbit / IgG


human, rat





Cat no : 13620-1-AP


Alpha 2,3 ST 2, Gal NAc6S, Sialyltransferase 4B, SIAT4 B, SIAT4B, ST3Gal II, ST3GAL2, ST3GalA.2, ST3GALII

Tested Applications

Positive WB detected inhuman colon tissue, HL-60 cells, human heart tissue, human liver tissue, human spleen tissue, K-562 cells
Positive IHC detected inrat heart tissue, human skin tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0

Recommended dilution

Western Blot (WB)WB : 1:500-1:1000
Immunohistochemistry (IHC)IHC : 1:50-1:500
Sample-dependent, check data in validation data gallery

Product Information

13620-1-AP targets ST3GAL2 in WB, IHC, ELISA applications and shows reactivity with human, rat samples.

Tested Reactivity human, rat
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen ST3GAL2 fusion protein Ag4528
Full Name ST3 beta-galactoside alpha-2,3-sialyltransferase 2
Calculated molecular weight 350 aa, 40 kDa
Observed molecular weight 55 kDa
GenBank accession numberBC036777
Gene symbol ST3GAL2
Gene ID (NCBI) 6483
Conjugate Unconjugated
Form Liquid
Purification Method Antigen affinity purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

Beta-galactoside alpha-2,3-sialyltransferase 2 (ST3GAL2) is a sialyltransferase (ST) that transfers sialic acid from the activated donor CMP-sialic acid to the glycan terminus of a glycolipid or glycoprotein. ST3GAL2 contains two putative N-glycosylation sites (Asn92 and Asn211), which are mainly responsible for GD1a and GT1b ganglioside biosynthesis in the brain. ST3GAL2 belongs to the sialyltransferase family, which mediates the terminal modification of glycoproteins and glycolipids. ST3GAL2 has been found to play a role in obesity, aging, and malignant diseases (PMID: 34319453). The calculated molecular weight of ST3GAL2 is 40 kDa, but the observed is 55 kDa, which may be the glycosylation form of ST3GAL2.


Product Specific Protocols
WB protocol for ST3GAL2 antibody 13620-1-APDownload protocol
IHC protocol for ST3GAL2 antibody 13620-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols